Switzerland's Unilabs Said to Draw Sonic, Cinven, PAI Interest

  • Sale of diagnostics provider also attracts Denmark's Novo
  • Geneva-based Unilabs could fetch as much as 1.5 billion euros

The sale of Swiss diagnostics company Unilabs SA has drawn interest from companies including Australia’s biggest listed medical-test provider, Sonic Healthcare Ltd., and buyout firms such as Cinven, people familiar with the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.